用毒动力学-毒动力学模型识别和预测延迟死亡率.
1DEBtox Research, Stevensweert, The Netherlands.
Environmental toxicology and chemistry
|February 28, 2024
概括
标准毒性测试经常错过延迟死亡率,即暴露结束后发生死亡. 毒动力学-毒动力学 (TKTD) 模型可以捕捉到这一点,但短期测试可能无法预测它.
科学领域:
- 生态毒理学 生态毒理学
- 环境化学环境化学
- 毒理学 毒理学 毒理学
背景情况:
- 生态毒理学中的标准化毒性测试经常忽略了毒性影响的时间维度.
- 延迟死亡率,在毒性物质暴露停止后出现不良影响,突显了时间依赖性毒性的重要性.
研究的目的:
- 评估毒动力学-毒动力学 (TKTD) 模型在通用统一值生存模型 (GUTS) 框架内的能力,以捕捉延迟死亡.
- 通过短期标准生态毒性测试来评估延迟死亡的可预测性.
主要方法:
- 对Daphnia magna中化诺毒性发表的数据集的分析,该数据集显示出显著的延迟死亡率 (作为死亡代理的固定).
- 应用GUTS随机死亡模型来分析时间依赖的毒性数据.
主要成果:
- GUTS随机死亡模型成功地在数据集中捕捉了延迟死亡率,包括延长的恢复阶段.
- 最重要的是,标准的两天测试不会预测这些延迟的毒性影响.
- 这项研究表明,对于延迟死亡等现象,标准急性试验设计的预测能力有限.
结论:
- TKTD建模提供了对毒性的时间方面的洞察力,但在从严格限制的标准测试中推断效应方面存在局限性.
- 延迟毒性现象需要进一步进行结构化调查,以确定其流行程度和生态影响.
- 标准生态毒理学试验可能会低估某些毒素的全部影响,因为它们的时间依赖性.
关键词:
水生物质毒理学研究达夫尼亚大麦格纳 (Daphnia magna) 是一个大的植物.延迟的毒性 延迟的毒性剂量反应建模剂量反应建模一般统一的生存值模型 (GUTS)死亡率 死亡率 死亡率在 TKTD 建模中.毒动力学 毒动力学 毒动力学毒动力学 毒动力学 毒动力学更多相关视频
相关概念视频
01:26Pharmacokinetic Models: Comparison and Selection Criterion
71
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
71
01:20Pharmacokinetic Models: Overview
682
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
682
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
39
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
39
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
69
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
69
00:57Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
79
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
79
01:13Physiological Pharmacokinetic Models: Assumption with Protein Binding
44
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
44